Evidence map›Paper›PMID 40884054›Full record

ReviewImmunological reviews2025

Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures.

Amy Cross, Jennifer Shelley, Rebecca Newman, Jessica Strid, Alice E Denton

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amy CrossRespiratory, Immunology & Inflammation Research Unit, GlaxoSmithKline, Stevenage, UK.
Jennifer ShelleyDepartment of Immunology and Inflammation, Imperial College London, London, UK.
Rebecca NewmanRespiratory, Immunology & Inflammation Research Unit, GlaxoSmithKline, Stevenage, UK.
Jessica StridDepartment of Immunology and Inflammation, Imperial College London, London, UK.
Alice E DentonDepartment of Immunology and Inflammation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-4580-3443

Funding

Medical Research Council MR/V009591/1Wellcome Trust 215488/Z/19/Z
6 · The paper itself

Abstract

Tertiary lymphoid structures (TLSs) are organized aggregates of lymphocytes, myeloid cells, and stromal cells that form at sites of inflammation, providing adaptive immune responses outside of secondary lymphoid organs (SLOs). Found in various pathological conditions-including chronic infections, cancer, organ transplantation, autoimmune diseases, and allergy-the presence of TLSs is linked to potentiation of local immunity. TLSs can be beneficial or detrimental, depending on context, and have been implicated as prognostic for disease severity and therapy response. Architecturally, TLSs resemble SLOs with distinct T and B cell areas supported by fibroblasts that secrete chemokines and cytokines that support immune cells. These structures must be created de novo in non-lymphoid tissues; thus, the steps for TLS formation mimic, but do not completely copy, those of SLO formation. The accumulation of immune cells in tissues in inflammatory settings can initiate remodeling of tissue fibroblasts, leading to TLS formation; this process is common across tissues, although there are tissue- and disease-specific pathways that impact TLS formation in certain contexts. This review will explore the immune-stromal crosstalk in kidney, lung, and skin TLSs across a range of disease settings, highlighting shared as well as tissue-specific mechanisms for TLS formation.

Indexed as

FibroblastsKidneyLungSkinTertiary Lymphoid StructuresAnimalsCell CommunicationHumansInflammationfibroblastgerminal centerkidneylungskintertiary lymphoid structure

Identifiers

PMID40884054
PMCPMC12397720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.